RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
A NEW COST-EFFECTIVENESS FRAMEWORK FOR MODELING ANKYLOSING SPONDYLITIS TREATMENTS
Graham, C., Gunda, P., Miles, L., Jugl, SM., Palaka, E., & McBride, D. (2016). A NEW COST-EFFECTIVENESS FRAMEWORK FOR MODELING ANKYLOSING SPONDYLITIS TREATMENTS. Value in Health, 19(3), A234-A234. https://doi.org/10.1016/j.jval.2016.03.1152
Even though the common Markov structure used in existing HTA submissions for AS treatments incorporates most aspects of disease progression, areas for improvement were identified. The proposed model matches clinical practice and improves decision making for biologic treatments.